The State Street SPDR S&P Aerospace & Defense ETF (XAR) seeks to track the total return of the S&P Aerospace & Defense Select Industry Index before fees and expenses. The fund uses a sampling strategy and remains effectively fully invested in the aerospace and defense segment of the U.S. industrials sector, with approximately 50 holdings and roughly $6 billion in assets under management. Its net expense ratio stands at 0.35%.
One defining feature of XAR is its equal-weighted, or modified equal-weighted, structure. Rather than concentrating assets in the largest defense primes, the fund spreads weight nearly evenly across its constituents, so each position typically represents roughly 2% to 3% of the portfolio. Recent top holdings include RTX, Axon Enterprise, StandardAero, Hexcel, General Dynamics, HEICO, GE Aerospace, Howmet Aerospace, Lockheed Martin, and Boeing. This approach gives smaller suppliers and mid-cap manufacturers a larger footprint than in cap-weighted funds, meaning XAR's performance is strongly shaped by the broader aerospace and defense supply chain.
The aerospace and defense industry sits at the intersection of government budgets, commercial air travel, and global security policy. Defense primes depend on multi-year procurement cycles and national budget appropriations, while commercial aerospace names are driven by aircraft production rates, airline fleet demand, and the aftermarket for parts and services. Suppliers across the value chain are influenced by raw-material costs, skilled-labor availability, and supply-chain bottlenecks.
The broader macroeconomic environment also matters. Higher interest rates raise the discount rate applied to the long-duration cash flows that characterize many defense contractors, pressuring valuations. Persistent inflation and elevated financing costs can weigh on capital-goods demand and squeeze margins at suppliers. Against this backdrop, the sector has faced a more cautious tape, with investors reassessing growth expectations and the pace of budget expansion. I also checked this using Tickeron’s AI Screener to see how the ETF compares to others in the industry.
XAR has moved lower in recent weeks, declining approximately 9% over the trailing 30 days and roughly 19% over the trailing quarter. The pullback has been gradual and trend-driven rather than a single-event shock, with the fund giving back much of the gains it registered earlier in the year.
The equal-weight design helps explain the magnitude of the move. Because mid- and small-cap aerospace and defense names carry a larger collective weight than in market-cap funds, XAR is more exposed to the valuation compression and de-risking that tend to hit smaller, higher-multiple industrials first. Commercial aerospace suppliers and newer entrants, which can be more sensitive to financing conditions and delivery timing, have been a meaningful source of the fund's underperformance relative to its cap-weighted peers. Defensive mega-cap primes have held up relatively better, but their smaller footprint in an equal-weight portfolio limits the cushion they provide. From what I see, this dynamic is important because it highlights how construction methodology affects outcomes in the current environment.
Looking ahead, several structural factors are likely to shape XAR. Defense budget negotiations and procurement timelines will remain central, as multi-year appropriations influence revenue visibility for primes and suppliers alike. Commercial aerospace remains a key swing factor, with aircraft delivery rates, aftermarket demand, and airline capital expenditure determining the earnings trajectory of many holdings.
Interest rates and inflation will also matter. A higher-for-longer rate environment could keep pressure on long-duration valuations, while any easing could support a re-rating of the sector's more growth-oriented names. Supply-chain normalization, labor costs, and the pace of new platform development are additional variables. Because XAR is equal-weighted, investors should monitor the performance of mid-cap suppliers and emerging space and defense entrants as closely as the established primes. These structural drivers, rather than short-term headlines, are likely to define the fund's positioning through 2026. I'm watching this closely as the data evolves.
In my own analysis, I often rely on Tickeron’s AI Screener to surface relevant securities and compare performance characteristics across the aerospace and defense space. The platform allows filtering by technical indicators, fundamentals, and AI-generated signals, which helps streamline the process of building and refining a watchlist without manual effort. This approach has proven useful when evaluating equal-weighted exposure like that in XAR.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Aroon Indicator for XAR entered a downward trend on October 23, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator formed such a pattern. In 112 of the 122 cases the stock moved lower. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 49 cases where XAR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for XAR just turned positive on October 15, 2026. Looking at past instances where XAR's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
Following a +0.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where XAR advanced for three days, in 291 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
XAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Industrials